Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01947049 · ClinicalTrials.gov registry record · NA
Influenza Diagnosis, Treatment and Surveillance With Xpert Flu
A NA study, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 2,011
- Enrollment target
NCT01947049: Completed NA study, sponsored by Johns Hopkins University.
NCT01947049 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 2,011 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01947049, a NA study, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,011 participants
- Enrollment target
Study Summary
The purpose of this study is to: 1. Evaluate the clinical performance of a newly available highly-sensitive rapid influenza test, Xpert Flu. 2. Derive and validate an adult clinical decision guideline to guide clinical testing of influenza patients who meed CDC criteria for antiviral treatment. 3. Evaluate impact of rapid influenza testing for antiviral treatment. 4. Determine cost effectiveness of influenza testing and treatment strategies.
Primary Outcome
The primary outcome is the sensitivity and specificity of Cepheid Xpert Flu in detecting Influenza, as well as the positive and negative predictive value.
Interventions
- OTHER Rapid Influenza Testing with Xpert Flu
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,011 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-06-30 |
| Phase | NA |
What the finished NCT01947049 record still lists
NCT01947049 is an interventional study that assigns participants to a tested intervention. Its 2,011 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% higher).
The record links to 0 conditions, and to 1 intervention - of which Rapid Influenza Testing with Xpert Flu is the first listed.
NCT01947049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01947049 about?
NCT01947049 is a clinical study titled "Influenza Diagnosis, Treatment and Surveillance With Xpert Flu". The purpose of this study is to: 1. Evaluate the clinical performance of a newly available highly-sensitive rapid influenza test, Xpert Flu. 2. Derive and validate an adult clinical decision guideline to guide clinical testing of influenza patients who meed CDC criteria for antiviral treatment. 3. ...
What is the current status of trial NCT01947049?
This trial is currently completed. It is a NA study. The enrollment target is 2,011 participants. The study started on 2013-07. Estimated completion is 2014-06-30.
What interventions are being tested in trial NCT01947049?
The interventions under investigation include: Rapid Influenza Testing with Xpert Flu (OTHER).
Who is sponsoring clinical trial NCT01947049?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01947049's enrollment target sits among peer trials
2,011 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia